Abstract

EFFICACY OF A NOVEL UNANI DRUG KATAN (LINUM USITATISSIMUM) IN THE MANAGEMENT OF BPH AND CARCINOMA PROSTATE. A NARRATIVE REVIEW

Mohd Tarique*, Tafseer Ali and Iqbal Aziz

.

Abstract

Benign prostatic hyperplasia (BPH) is gradually becoming more common. While traditional medications such a1-adrenergic receptor antagonists and 5a-reductase inhibitors have been effective in treating BPH, their unfavourable side effects have prompted a greater interest in finding alternative treatments. Furthermore, despite the fact that surgery has also been touted as a reliable therapy, its expense and hazards prevent it from being used as a routine form of treatment. Due to its potential to prevent a number of diseases linked to reactive oxygen species and/or free radicals. Katan (flax seed) has recently attracted the attention of the general public. Prostate cancer is a hormone-related cancer that appears to be responsive to the anticarcinogenic effects of lignan. Flax seed supplementation for ∼30 days before surgery significantly reduced the tumor proliferation rates among men who elected prostatectomy for localized prostate cancer. Their function in the treatment of BPH and carcinoma prostate, however, has not been studied. Hence, this analysis assesses their potential for managing BPH and Ca Prostate and their mode of operation. To determine the present state of knowledge on this idea, literature searches were done in a number of electronic databases, including PubMed, Google Scholar, and Medline. The results from these databases indicate that while Katan (Flax Seed) may not be able to completely replace the requirement for the current medications in the management of BPH and Ca Prostate, it does show potential and could be investigated by researchers in this field.

Keywords: Benign Prostatic Hyperplasia; Carcinoma Prostate; Polyphenols.